Loading clinical trials...
Loading clinical trials...
Botulinum Toxin Injection in the Upper Esophageal Sphincter for Retrograde-cricopharyngeus Dysfunction: a Prospective, Double Blind, Placebo-controlled Trial
Conditions
Interventions
botulinum toxin type A
Sodium Chloride 0.9% Inj
Locations
1
Belgium
AZ Delta
Roeselare, Belgium
Start Date
September 2, 2024
Primary Completion Date
December 1, 2025
Completion Date
March 1, 2027
Last Updated
December 8, 2025
Lead Sponsor
AZ Delta
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions